|
FY2026
12 months to Aug 31, 2026
|
FY2025
12 months to Aug 31, 2025
|
FY2024
12 months to Aug 31, 2024
|
FY2023
12 months to Aug 31, 2023
|
FY2022
12 months to Aug 31, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Adjustments for non-cash income and expenses: | |||||
| Depreciation | |||||
| Amortization | |||||
| Intangible asset impairment | |||||
| Stock based expense | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivables | |||||
| Inventories | |||||
| Deposit, prepayments and other receivables | |||||
| Operating lease right-of-use assets | |||||
| Operating lease right-of-use assets and liabilities, net | |||||
| Accounts payable and accruals | |||||
| Deferred revenue | |||||
| Operating lease liabilities | |||||
| Other payables | |||||
| Increase in amounts due to shareholders | |||||
| Net cash used in operations | |||||
| Cash flows from investing activity | |||||
| Purchase of property, plant and equipment | |||||
| Cash used in investing activity | |||||
| Cash flows from financing activities | |||||
| Loan from shareholders | |||||
| Loans from related parties and other shareholders, net (including related parties of $574,201 and $1,009,396, respectively) | |||||
| Proceeds from issuing short-term borrowing | |||||
| Payments of hire purchase | |||||
| Payment of deferred offering costs | |||||
| Net cash provided by financing activities | |||||
| Net increase/(decrease) in cash and cash equivalents | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Supplemental cash flow information: | |||||
| Cash paid for interest | |||||
| Supplemental disclosure of non-cash investing and financing activities: | |||||
| Common stock issued for consulting service in related to Initial public offering | |||||
Loading...